Primary and secondary progressive MS subjects in clinical trials: Are they similar?

The requested reference [215bb7bb16a77aa7ca23ac510a883967765057de] no longer exists in our database. It has been replaced by the current reference: [f571f57e1967080c8a1870d8405d5f940113c580]

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: d14539d9655bc19a83e54339c686c0c13a68f13a
First added on: Feb 08, 2025